(2S,3S,4S,5R,6S)-6-(5-((S)-5,7-Dihydroxy-4-oxochroman-2-yl)-2-methoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

Catalog No. :
ACUBBG637
CAS No. :
150985-66-3
Molecular Formula :
C22H22O12
Molecular Weight :
478.41

IUPAC Name:(2S,3S,4S,5R,6S)-6-(5-((S)-5,7-dihydroxy-4-oxochroman-2-yl)-2-methoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

(2S,3S,4S,5R,6S)-6-(5-((S)-5,7-Dihydroxy-4-oxochroman-2-yl)-2-methoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3S,4S,5R,6S)-6-(5-((S)-5,7-Dihydroxy-4-oxochroman-2-yl)-2-methoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
IUPAC Name(2S,3S,4S,5R,6S)-6-(5-((S)-5,7-dihydroxy-4-oxochroman-2-yl)-2-methoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Molecular FormulaC22H22O12
Molecular Weight478.41
SMILESCOC1=CC=C([C@@H]2CC(=O)C3=C(C=C(O)C=C3O)O2)C=C1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O
InChI KeyPJAUEKWZQWLQSU-ZQUMRXHJSA-N
SynonymHesperetin 3'-O-β-D-Glucuronide;β-D-Glucopyranosiduronic acid, 5-[(2S)-3,4-dihydro-5,7-dihydroxy-4-oxo-2H-1-benzopyran-2-yl]-2-methoxyphenyl;Hesperetin 3’-O-β-D-Glucuronide;Hesperetin 3’-O-Beta-D-Glucuronide;Hesperetin 3'-O-beta-D-glucuronide
CAS No.150985-66-3

Synthetic Route by SureRoute

1. ACUBBG637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUBBG637 route product structure diagram
    ACUBBG637150985-66-3
Inquiry

2. ACUBBG637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUBBG637 route product structure diagram
    ACUBBG637150985-66-3
Inquiry

Comments (0)